$Direxion Daily 20+ Year Treasury Bull 3X Shares ETF (TMF.US)$ The bond buying back of the fund is over, and the bonds are being sold, it's over.Selling stocks and selling bonds as well, with concerns about the New Year's decline and no hedge. When the interest rate was lowered in September, there was a welcome decrease from the long-lasting high interest rate policy, leading the flow from bonds to stocks. Under a strong economy, it is not just a matter of M1M2 dimensions at the moment, but a discussion on whether inflation will progress further under the Trump policy, how far it will go. Inflation is also embraced as prices rise, serving as evidence of a strong economy. Even if it rises, if it continues to be bought, prices will not fall. In 2025, tariffs, tax cuts, immigration rejection, bond issuances, and temporary bond issuances will further raise interest rates, delaying rate cuts. With each inflation indicator appearing, the 30-year bond yield will increase, and unfortunately, the possibility of a rate hike being mentioned at a Federal Reserve meeting or taking action for a rate hike in the coming years would regress into a high interest rate state.Even if the unemployment rate rises a little, a rate cut cannot be implemented. If it is, there is a concern that inflation will progress further, leading to an increase in interest rates.I think it's dangerous to mix up short-term bonds and long-term bonds when considering bond price movements.

$AEON Biopharma (AEON.US)$ The recent news about Ion Biopharma's confirmed underwriting public offering may affect the stock price, but it is difficult to predict whether the stock price will actually rise. Stock prices are influenced by many factors such as investor reactions, market conditions, and company performance.
The current stock price is about $0.17, which is lower than the recent public offering price of $0.50. If this fundraising through the public offering is successful and the company's growth strategy progresses smoothly, there is a possibility of the stock price rising, but on the other hand, if the market reaction is negative, it could also decline.

$AEON Biopharma (AEON.US)$
I just bought 15,000 shares at $0.17 ☺️ The real battle starts now for Ion.

$SEALSQ Corp (LAES.US)$
Hoo! You're the best!
The hard work of making up for the decline of last weekend with short trades has paid off 🤣

$SEALSQ Corp (LAES.US)$
I want to take profit, but I feel like it will grow more, so I plan to hold 🤝 aiming to maximize profits ✨

» Holdings: 75
» Holdings in Top 20: 70.21%
» Qtr over Qtr Change**: +21.81%
Top Holdings:
$Ascendis Pharma A/S (ASND.US)$
$Vaxcyte (PCVX.US)$
$Legend Biotech (LEGN.US)$
$Janux Therapeutics (JANX.US)$
$Aerovate (AVTE.US)$
$Rhythm Pharmaceuticals (RYTM.US)$
$Evolent Health (EVH.US)$
$NewAmsterdam Pharma (NAMS.US)$
$RxSight (RXST.US)$
$TYRA BIOSCIENCES, INC. (TYRA.US)$
$Edgewise Therapeutics (EWTX.US)$
$4D Molecular Therapeutics (FDMT.US)$
$Biogen (BIIB.US)$
$PepGen (PEPG.US)$
...

$SES AI Corp (SES.US)$
SES Artificial Intelligence will participate in the 2025 CES Show.
Just waiting for the response here, right? ☺️

$SEALSQ Corp (LAES.US)$
When Holder wakes up on New Year's morning, he seems to turn pale.